Year
2023
-
ANANDA Scientific announces FDA approval of the IND for a clinical trial exploring treatment of Social Anxiety Disorder (SAD)
-
X4 Pharmaceuticals announces positive top-line results for WHIM Syndrome drug
-
Addressing Unmet Needs of Dementia With Lewy Bodies
-
Donanemab Shows Greater Ability to Clear Amyloid Plaque Than Aducanumab
-
Pfizer’s BLA for Its RSV Vaccine Gets Priority Review
-
Ifenprodil for IPF Earns Orphan Drug Designation
-
Olutasidenib Gains FDA Approval for IDH1-Mutated Relapsed/Refractory Acute Myeloid Leukemia
-
EU Approves Takeda’s Dengue Vaccine
-
Istesso’s Idiopathic Pulmonary Fibrosis Candidate Gains Fast Track
-
SABCS: Pharmas show their working in HR+/HER2- breast cancer